Pain Palliation of Bone Metastases

Production, Quality Control and Dosimetry of Radiopharmaceuticals

Edited by International Atomic Energy Agency

Radionuclide therapy using bone targeting radiopharmaceuticals is an effective palliative care option to reduce pain associated with advanced disease with bone metastases. Over the last 20 years, suitable therapeutic radionuclides are more widely available, meaning that the benefits of pain palliation therapy could reach more patients. This publication provides a broad overview on the current status of radiopharmaceuticals for bone pain palliation. It covers production of radionuclides, identification of bone seeking carrier molecules, preparation of stable complexes, in vitro and in vivo evaluations and dosimetry studies which are part of the development of these radiopharmaceuticals for clinical use. Details on production and quality control of the currently available products, provided here will be of use to scientists involved in the development of these radiopharmaceuticals.

Bernan Distribution / International Atomic Energy Agency

Pages: 141 • Trim: 6¼ x 9½

978-92-0150022-9 • Paperback • October 2023 • $55.00 • - Currently out of stock. Copies will arrive soon.

Subjects: Technology & Engineering / Power Resources / General

Pain Palliation of Bone Metastases

Production, Quality Control and Dosimetry of Radiopharmaceuticals

Paperback

Summary

Radionuclide therapy using bone targeting radiopharmaceuticals is an effective palliative care option to reduce pain associated with advanced disease with bone metastases. Over the last 20 years, suitable therapeutic radionuclides are more widely available, meaning that the benefits of pain palliation therapy could reach more patients. This publication provides a broad overview on the current status of radiopharmaceuticals for bone pain palliation. It covers production of radionuclides, identification of bone seeking carrier molecules, preparation of stable complexes, in vitro and in vivo evaluations and dosimetry studies which are part of the development of these radiopharmaceuticals for clinical use. Details on production and quality control of the currently available products, provided here will be of use to scientists involved in the development of these radiopharmaceuticals.

Details

Bernan Distribution / International Atomic Energy Agency

Pages: 141 • Trim: 6¼ x 9½

978-92-0150022-9 • Paperback • October 2023 • $55.00 • - Currently out of stock. Copies will arrive soon.

Subjects: Technology & Engineering / Power Resources / General

Author

The International Atomic Energy Agency (IAEA) is the world's center of cooperation in the nuclear field. It was set up as the world's "Atom's for Peace" organization in 1957 within the United Nations family. The Agency works with its Member States and multiple partners worldwide to promote safe, secure and peaceful nuclear technologies.